Advertisement
Skip to Content

Beam Therapeutics Inc BEAM Stock Quote

| Rating as of

NASDAQ: BEAM

Last close prices updated as of May 26, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 32.37
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Blend
  • Day Range 31.41  –  32.69
  • Year Range 28.04  –  73.27
  • Market Cap 2.4672 Bil
  • Volume / Avg 516,261.0 /  967,452.9
  • Price / Sales 29.93
  • Price / Book 3.24
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis BEAM

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BEAM

Company Profile BEAM

Business Description

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Contact
238 Main Street
Cambridge, MA, 02142
Industry Biotechnology
Employees 507

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Beam Therapeutics Inc

XNAS: BEAM

Mirati Therapeutics Inc

XNAS: MRTX

Homology Medicines Inc

XNAS: FIXX

Avrobio Inc

XNAS: AVRO
Price
32.3738.461.021.18
Currency
USDUSDUSDUSD
Change
+$0.16 (0.50%) +$0.06 (0.16%) +$0.01 (0.99%) +$0.03 (2.61%)
Market Cap
2.47 Bil2.24 Bil58.95 Mil52.04 Mil
Industry
Biotechnology Biotechnology Biotechnology Biotechnology
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Beam Therapeutics Inc Stock

No. BEAM does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BEAM’s market cap is 2.47 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BEAM’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BEAM’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BEAM’s historical performance against its industry peers and the overall market.